1-2 of 2
Larry I. Magpantay
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immune Activation and Microbial Translocation as Prognostic Biomarkers for AIDS-Related Non-Hodgkin Lymphoma in the AMC-034 Study

Laura E. Martínez, Shelly Lensing, Di Chang, Larry I. Magpantay, Ronald Mitsuyasu, Richard F. Ambinder, Joseph A. Sparano, Otoniel Martínez-Maza, Marta Epeldegui
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (16): 4642–4651.
https://doi.org/10.1158/1078-0432.CCR-20-4167
Published: 15 August 2021
View article titled, Immune Activation and Microbial Translocation as Prognostic Biomarkers for AIDS-Related Non-Hodgkin Lymphoma in the AMC-034 Study
Open the PDF for Immune Activation and Microbial Translocation as Prognostic Biomarkers for AIDS-Related Non-Hodgkin Lymphoma in the AMC-034 Study in another window
Includes: Supplementary data
Journal Articles

Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial)

Marta Epeldegui, Jeannette Y. Lee, Anna C. Martínez, Daniel P. Widney, Larry I. Magpantay, Deborah Regidor, Ronald Mitsuyasu, Joseph A. Sparano, Richard F. Ambinder, Otoniel Martínez-Maza
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2): 328–336.
https://doi.org/10.1158/1078-0432.CCR-14-0466
Published: 14 January 2016
View article titled, Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial)
Open the PDF for Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial) in another window